Munro Partners
- SEC CIK
- 0001768744
- Latest filing
- Aug 10, 2026
BSX holding history
Boston Scientific Corp in every 13F filed by Munro Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BSX overviewAll 13F holders of BSXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,256,810−100.0% | Sold out | Holders |
| Q4 2025 | 1,256,810 | $119.8M | 3.3% | +14,730+1.2% | Added | Holders |
| Q3 2025 | 1,242,080 | $121.3M | 3.3% | +283,475+29.6% | Added | Holders |
| Q2 2025 | 958,605 | $103.0M | 3.2% | +356,150+59.1% | Added | Holders |
| Q1 2025 | 602,455 | $60.8M | 2.9% | −315,770−34.4% | Reduced | Holders |
| Q4 2024 | 918,225 | $82.0M | 2.9% | +184,580+25.2% | Added | Holders |
| Q3 2024 | 733,645 | $61.5M | 2.2% | −173,300−19.1% | Reduced | Holders |
| Q2 2024 | 906,945 | $69.8M | 2.6% | −2,840−0.3% | Reduced | Holders |
| Q1 2024 | 909,785 | $62.3M | 2.2% | −1,305−0.1% | Reduced | Holders |
| Q4 2023 | 911,090 | $52.7M | 2.4% | +409,515+81.6% | Added | Holders |
| Q3 2023 | 501,575 | $26.5M | 1.3% | +501,575 | New | Holders |